Shares of BioNexus Gene Lab Corp. (NASDAQ:BGLC – Get Free Report) traded down 1.4% during mid-day trading on Tuesday . The stock traded as low as $2.15 and last traded at $2.16. 6,790 shares traded hands during mid-day trading, a decline of 77% from the average session volume of 30,130 shares. The stock had previously closed at $2.19.
BioNexus Gene Lab Stock Up 7.1%
The company has a market cap of $5.11 million, a price-to-earnings ratio of -1.43 and a beta of 4.06. The company has a current ratio of 6.53, a quick ratio of 5.69 and a debt-to-equity ratio of 0.01. The firm’s fifty day moving average price is $2.16 and its 200-day moving average price is $2.83.
BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) last announced its quarterly earnings results on Friday, May 15th. The company reported ($0.23) earnings per share (EPS) for the quarter. The firm had revenue of $0.02 million during the quarter. BioNexus Gene Lab had a negative net margin of 54.70% and a negative return on equity of 37.43%.
Hedge Funds Weigh In On BioNexus Gene Lab
About BioNexus Gene Lab
BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.
Recommended Stories
- Five stocks we like better than BioNexus Gene Lab
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Receive News & Ratings for BioNexus Gene Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNexus Gene Lab and related companies with MarketBeat.com's FREE daily email newsletter.
